Financial Performance - The company's revenue for Q3 2023 was CNY 670,971,756.95, representing a 2.21% increase year-over-year[4] - Total operating revenue for Q3 2023 was CNY 1,879,376,893.40, an increase of 1.4% compared to CNY 1,855,445,428.54 in Q3 2022[18] - Net profit for Q3 2023 was CNY 5,347,275.47, a decrease of 57.4% from CNY 12,551,334.97 in Q3 2022[19] - The net profit attributable to shareholders of the parent company was CNY 7,608,825.93, down 57.9% from CNY 18,073,667.73 in the previous year[19] - The company's basic earnings per share decreased by 3.36% to CNY 0.0051, while diluted earnings per share remained the same[4] - Basic and diluted earnings per share for Q3 2023 were both CNY 0.0086, compared to CNY 0.0205 in Q3 2022[19] - The company reported a total comprehensive income of CNY 16,287,667.86 for Q3 2023, compared to CNY 15,134,656.34 in the same period last year[19] Assets and Liabilities - Total assets at the end of the reporting period were CNY 3,021,859,054.12, reflecting a 1.41% increase from the end of the previous year[4] - Total liabilities as of the end of Q3 2023 amounted to CNY 1,182,698,807.07, slightly down from CNY 1,185,286,279.22 at the end of Q3 2022[18] - Total equity increased to CNY 1,839,160,247.05 in Q3 2023 from CNY 1,794,616,340.44 in Q3 2022, marking a growth of 2.5%[18] - The company’s total liabilities and equity structure remains robust, supporting future growth and operational strategies[15] Cash Flow - The operating cash flow net amount for the year-to-date period was CNY -590,140,802.25, a significant decrease of 91.07% compared to the previous year[10] - The net cash flow from operating activities was negative at CNY -590,140,802.25, worsening from CNY -308,859,078.96 year-over-year[22] - The total cash inflow from investment activities was CNY 25,943,053.50, a significant decrease from CNY 293,611,743.85 in the same period last year[22] - The net cash flow from financing activities was CNY 201,706,086.01, compared to CNY 36,716,434.63 in the previous year, indicating a substantial increase[23] - The total cash and cash equivalents at the end of the period stood at CNY 610,074,861.19, up from CNY 591,538,982.06 year-over-year[23] - The company reported a total cash outflow from operating activities of CNY 2,798,974,381.97, compared to CNY 2,471,720,987.44 in the previous year, representing an increase of approximately 13.2%[22] Investments and Income - Investment income rose by 111.34% to CNY 2,846,369.13, driven by increased profits from equity method investments[9] - The fair value change income surged by 601.20% to CNY 1,009,546.15, attributed to gains from financial products[9] Operational Metrics - The accounts receivable increased by 36.74% to CNY 896,529,966.29, attributed to extended collection periods[7] - The company experienced a 42.60% increase in inventory, totaling CNY 542,846,446.37, due to higher project contract performance costs[7] - The company reported a significant increase in prepayments, which rose to ¥71,073,541.47 from ¥23,472,892.28, a growth of about 202.5%[15] - Research and development expenses for Q3 2023 were CNY 91,199,393.45, up 11.8% from CNY 81,655,101.24 in Q3 2022[18] Audit and Reporting - The company did not conduct an audit for the third-quarter report, as indicated in the financial statements[24]

宜通世纪科技股份有限公司 证券代码：300310 证券简称：宜通世纪 公告编号：2023-037 第五届监事会第五次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 宜通世纪科技股份有限公司（以下简称"公司"）第五届监事会第五次会议（以 下简称"本次会议"）通知及相关资料于 2023 年 10 月 20 日通过电子邮件发出。本次 会议于 2023 年 10 月 24 日在公司（广州市天河区科韵路 16 号广州信息港 C1 栋 10 楼）会议室以现场表决结合通讯表决的方式召开。本次会议应出席会议监事 3 名， 实际出席会议监事 3 名。本次会议符合《公司法》及《公司章程》的规定，本次会 议由公司监事会主席钟富标先生主持。 经出席会议全体监事认真研究并投票表决，一致通过以下议案： 一、审议通过《2023 年第三季度报告》 公司监事会对公司编制的 2023 年第三季度报告进行了认真严格的审核，并提出 了如下的书面审核意见： (1)公司 2023 年第三季度报告的编制和审议程序符合法律、行政法规、中国证 监会及《公司章程》的各项规定。 (2)公司 2023 ...

证券代码：300310 证券简称：宜通世纪 公告编号:2023-039 关于会计政策变更的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宜通世纪科技股份有限公司（以下简称"公司"）于 2023 年 10 月 24 日召 开第五届董事会第五次会议，审议通过了《关于会计政策变更的议案》，现将具 体内容公告如下： 一、会计政策变更概述 宜通世纪科技股份有限公司 （一）变更原因 2021 年 12 月 31 日，财政部发布了《企业会计准则解释第 15 号》（财会 [2021]35 号），其中"关于企业将固定资产达到预定可使用状态前或者研发过 程中产出的产品或副产品对外销售的会计处理"和"关于亏损合同的判断"内容 自 2022 年 1 月 1 日起施行。 根据上述文件的要求，公司对会计政策予以相应的 变更，自规定之日起开始执行。 2022 年 11 月 30 日，财政部发布了《企业会计准则解释第 16 号》（财会 [2022]31 号），"关于单项交易产生的资产和负债相关的递延所得税不适用初 始确认豁免的会计处理"内容自 2023 年 1 月 1 日起施行； " ...

宜通世纪科技股份有限公司 第五届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 宜通世纪科技股份有限公司（以下简称"公司"）第五届董事会第五次会议 （以下简称"本次会议"）通知及相关资料已于 2023 年 10 月 20 日通过电子邮 件送达公司全体董事、监事和高级管理人员。本次会议于 2023 年 10 月 24 日上 午以现场表决结合通讯表决的方式召开。本次会议应参加表决董事 9 名，实际参 加董事 9 名，其中董事史亚洲先生因工作原因未能出席会议，委托董事钟飞鹏先 生代为行使表决权。本次会议的召集和召开符合《中华人民共和国公司法》、《宜 通世纪科技股份有限公司董事会议事规则》及《公司章程》的有关规定，决议有 效。本次会议由公司董事长钟飞鹏先生主持。 证券代码：300310 证券简称：宜通世纪 公告编号：2023-036 董事会 2023 年 10 月 26 日 1 表决结果：9 票同意、0 票反对、0 票弃权。 特此公告。 宜通世纪科技股份有限公司 经出席会议全体董事认真研究并投票表决，通过以下议案： 一、审议通过《2023 年 ...

编号：2023-002 | 投资者关系活动类 | □特定对象调研 □分析师会议 | | --- | --- | | 别 | □媒体采访 □业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | √其他 （投资者集体线上接待） | | 参与单位名称及人 | 线上参与 2023 年广东证监局和广东上市公司协会联合 | | 员姓名 | 举办的投资者集体接待日的投资者 | | 时间 | 2023 年 09 月 19 日（星期二）下午 15:45-17:00 | | 地点 | 全景网（https://www.p5w.net/index.htm） | | 上市公司接待人员 | 董事长、总经理：钟飞鹏先生 | | 姓名 | 财务总监：黄革珍女士 | | | 董事会秘书：徐锡彬先生 | | | 投资者提出的问题及公司回复情况 | | | 公司就投资者在本次说明会中提出的问题进行了 | | | 回复： 1、请问公司有没有股权激励计划？ | | | 您好，目前暂时没有相关计划，若有相关计划公司 | | 投资者关系活动主 | 将依照规则进行披露，谢谢你的关注！ | | 要内容介绍 | 2、请介绍一下主 ...

近日，公司收到相关招标机构发出的中选通知书，获悉公司成为上述项目的 中标单位，现将具体情况公告如下： 证券代码：300310 证券简称：宜通世纪 公告编号：2023-035 宜通世纪科技股份有限公司 关于项目中标的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，并对公告 中的虚假记载、误导性陈述或者重大遗漏承担责任。 宜通世纪科技股份有限公司（以下简称"公司"） 于 2023 年 7 月 21 日在巨 潮资讯网（www.cninfo.com.cn）披露了《关于中标候选人公示的提示性公告》 （公告编号：2023-025），公司成为中国移动通信集团多个省份/地区 2023 年至 2026 年网络综合代维服务采购项目中标候选人之一。 一、公司中标项目的基本情况 | 序 | 项目名称 | 中标折 | 中选 | 预计中标金额（万 | | --- | --- | --- | --- | --- | | 号 | | 扣率 | 份额 | 元）（含税） | | 1 | 中国移动广东公司2023年至2026年网络 | 85% | 13% | 26,162.16 | | | 综合代维服务采购项目 | | | | | ...

中国证券监督管理委员会广东监管局 行政监管措施决定书 〔2023〕102 号 关于对石磊采取出具警示函措施的决定 石磊： 经查，宜通世纪科技股份有限公司（以下简称宜通世纪或 公司）存在以下违法行为： 2016 年 10 月，宜通世纪启动重大资产重组，以发行 2,178.99 万股及支付现金 44,000 万元的方式向深圳市倍泰健 康测量分析技术有限公司（以下简称倍泰健康）原实际控制人 方炎林等 16 名交易对手方收购倍泰健康 100%股权，交易总 对价为 10 亿元。收购完成后，倍泰健康成为宜通世纪的全资 子公司，纳入宜通世纪合并会计报表编制范围。 2017 年 5 月 1 日至 12 月 31 日，倍泰健康采取在内部指 使员工以虚假合同在 ERP 系统中虚构订单，在 ERP 系统中虚 1 拟采购收货、生产、发货等全套资料的方式，在外部与客户策 划签订虚假合同或未履行合同，利用控制的个人及企业账户资 金转款，提供资金供交易对方支付货款等手段进行财务舞弊。 通 过 上 述 财 务 舞 弊 行 为 ， 倍 泰 健 康 合 计 虚 增 业 务 收 入 9,734.39 万元，虚增成本 5,260.99 万元，虚增利 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of 1.5 billion RMB, representing a year-on-year growth of 20%[1]. - The company's operating revenue for the first half of 2023 was ¥1,208,405,136.45, representing a year-on-year increase of 0.79% compared to ¥1,198,976,774.44 in the same period last year[23]. - The net profit attributable to shareholders of the listed company decreased by 76.89% to ¥3,098,865.98 from ¥13,407,030.17 in the previous year[23]. - The net profit after deducting non-recurring gains and losses fell by 86.81% to ¥1,282,334.21 from ¥9,719,519.96 year-on-year[23]. - The total profit for the first half of 2023 was CNY 2.05 million, a decrease of CNY 9.47 million or 82.3% compared to the same period last year[74]. - The company's gross profit amounted to CNY 130.03 million, up CNY 7.03 million or 5.71% year-on-year, with a gross margin of 10.76%, an increase of 0.5 percentage points from the previous year[74]. - The company reported a net cash flow from operating activities of -¥460,707,265.57, a decrease of 76.60% from -¥260,874,316.34 in the same period last year[82]. - The company’s investment income amounted to ¥1,915,070.29, accounting for 93.26% of total profit, primarily from equity method recognition of affiliated company profits and dividends from China Unicom[99]. User Growth and Market Expansion - User data showed an increase in active users, reaching 5 million, which is a 15% increase compared to the previous year[1]. - The company provided a future outlook, projecting a revenue growth of 20% for the next fiscal year, driven by new product launches and market expansion[161]. - The overall market expansion strategy includes entering two new international markets by the end of 2024[161]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[161]. Research and Development - The company is investing heavily in R&D, with a budget allocation of 200 million RMB for new technologies and product development[1]. - Investment in R&D increased by 30% year-over-year, focusing on innovative technologies and product development[161]. - The company achieved a research and development investment of 58.4 million yuan, accounting for 4.83% of its revenue in the first half of 2023[63]. - The company has increased its R&D investment in 5G and IoT applications, achieving progress in these areas[41]. Strategic Acquisitions and Partnerships - The company is considering strategic acquisitions to enhance its technology portfolio, with a target of acquiring at least one company by the end of the year[1]. - A strategic acquisition of a competitor is expected to be finalized by Q4 2023, which will enhance the company's product offerings[161]. - The acquisition of 100% equity in Beitai Health is part of the company's strategic expansion efforts[154]. - The company aims to enhance its market position through strategic acquisitions and partnerships[155]. Financial Stability and Risk Management - The management emphasized the importance of maintaining a strong balance sheet, with a current debt-to-equity ratio of 0.5, indicating financial stability[1]. - The company has identified key risks, including market competition and pricing pressures, and has outlined strategies to mitigate these risks[1]. - The company is at risk of revenue and gross margin decline due to major clients reducing outsourcing service prices and project scopes, necessitating a focus on local service systems and cost control[126]. Operational Efficiency and Cost Management - The company aims to improve operational efficiency by 15% through cost-cutting measures and process optimization[161]. - The company is focusing on developing new business areas and enhancing operational efficiency through strategic investments in R&D and marketing[79]. - The company is committed to enhancing its brand image through quality service and participation in community activities, which supports its long-term growth strategy[71]. Legal and Compliance Issues - The company is pursuing legal measures to recover a total of RMB 769,587,200 related to a court ruling against a former employee, facing risks of non-recovery due to the individual's financial situation[127]. - The company has received an administrative penalty decision from the China Securities Regulatory Commission, which poses a risk of investor compensation lawsuits[128]. - The company is actively seeking to protect the interests of its shareholders through legal means[164]. Social Responsibility and Employee Welfare - The company is dedicated to social responsibility, striving for a balance between economic benefits and societal contributions, promoting sustainable development[149]. - The company has implemented a comprehensive employee rights protection system, providing various insurances and regular health check-ups to ensure employee well-being[146]. - The company is committed to safety in production, adhering to a "safety first" principle and conducting extensive safety checks and training to minimize operational risks[147].

证券代码：300310 证券简称：宜通世纪 公告编号：2023-033 宜通世纪科技股份有限公司 关于公司董事收到中国证券监督管理委员会广东监管局《行 政监管措施决定书》和《结案通知书的》的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 宜通世纪科技股份有限公司(以下简称"公司"或"宜通世纪") 董事石磊先生于近 日收到中国证券监督管理委员会广东监管局出具的《关于对石磊采取出具警示函措 施的决定》（[2023]102 号）和《结案通知书》（广东证监结案字[2023]2 号） ，现 将有关情况公告如下： 一、行政监管措施决定书的相关内容: 石磊： 经查，宜通世纪科技股份有限公司（以下简称宜通世纪或公司）存在以下违法 行为： 宜通世纪公开披露的 2017 年年度报告存在虚假记载，有关行为违反了 2005 年 《证券法》第六十三条、第六十六条的规定构成 2005 年《证券法》第一百九十三条 第一款所述的信息披露违法行为。 你于 2016 年 8 月至 2022 年 9 月担任宜通世纪财务总监，任职期间存在履职尽 责不到位的问题，违反了《上市公司信息披露管理办法 ...

宜通世纪科技股份有限公司投资者关系活动记录表 编号：2023-001 投资者关系活动类 别 □特定对象调研 □分析师会议 □媒体采访 √业绩说明会 □新闻发布会 □路演活动 □现场参观 □其他 （请文字说明其他活动内容） 参与单位名称及人 员姓名 线上参与宜通世纪 2022 年度网上业绩说明会的投资者 时间 2023 年 04 月 28 日（星期五）下午 15:00-17:00 地点 "宜通世纪投资者关系"微信小程序 上市公司接待人员 姓名 董事长兼总经理：钟飞鹏先生 副总经理兼董事会秘书：徐锡彬先生 副总经理兼财务总监：黄革珍女士 独立董事：黄德汉先生 投资者关系活动主 要内容介绍 1、问：公司的案件什么时候结束，股价一直跌着喋喋不 休，公司有无应对办法。 答：您好！1、公司涉及的刑事案件已告一段落，后续公 司已对原子公司的原股东提起了民事索赔诉讼追偿，将 尽一切办法维护公司股东的利益。2、股价涨跌是资本市 场规律的体现，这是由多方面因素影响所致；公司会努 力做好自身的经营工作，坚持以良好的经营业绩来回报 股东，从而实现股东价值最大化；具体而言，公司将通 过积极拓展业务、扩大市场规模、优化项目资源配置， 通 ...